JP2004523557A5 - - Google Patents

Download PDF

Info

Publication number
JP2004523557A5
JP2004523557A5 JP2002567298A JP2002567298A JP2004523557A5 JP 2004523557 A5 JP2004523557 A5 JP 2004523557A5 JP 2002567298 A JP2002567298 A JP 2002567298A JP 2002567298 A JP2002567298 A JP 2002567298A JP 2004523557 A5 JP2004523557 A5 JP 2004523557A5
Authority
JP
Japan
Prior art keywords
optionally substituted
pharmaceutical composition
composition according
alkyl
pyrrolidone compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002567298A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004523557A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/005189 external-priority patent/WO2002067931A1/en
Publication of JP2004523557A publication Critical patent/JP2004523557A/ja
Publication of JP2004523557A5 publication Critical patent/JP2004523557A5/ja
Pending legal-status Critical Current

Links

JP2002567298A 2001-02-23 2002-02-22 チック、振せん、および関連疾患の治療 Pending JP2004523557A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27098701P 2001-02-23 2001-02-23
PCT/US2002/005189 WO2002067931A1 (en) 2001-02-23 2002-02-22 Treatment of tics, tremors and related disorders

Publications (2)

Publication Number Publication Date
JP2004523557A JP2004523557A (ja) 2004-08-05
JP2004523557A5 true JP2004523557A5 (https=) 2005-12-22

Family

ID=23033711

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002567298A Pending JP2004523557A (ja) 2001-02-23 2002-02-22 チック、振せん、および関連疾患の治療

Country Status (6)

Country Link
US (1) US20040116505A1 (https=)
EP (1) EP1379236A4 (https=)
JP (1) JP2004523557A (https=)
AU (1) AU2002245486B2 (https=)
CA (1) CA2438930A1 (https=)
WO (1) WO2002067931A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040242671A1 (en) * 2001-10-08 2004-12-02 Renee Grimee Use of 2-oxo-1-pyrrolidine derivatives for the preparation of a drug
US7427601B2 (en) * 2004-06-24 2008-09-23 Schwarz Pharma Ag Method for treating tremor
US20070259859A1 (en) * 2006-05-04 2007-11-08 De Bruin Natasja M W J Muscarinic agonists to treat impulse control disorders
EA014915B1 (ru) * 2006-05-04 2011-02-28 Солвей Фармасьютикалс Б.В. Мускариновые агонисты для лечения расстройств контроля над побуждениями
ES2865504T3 (es) 2008-10-16 2021-10-15 Univ Johns Hopkins Procedimientos y composiciones para la mejora de la función cognitiva
AU2011215870B2 (en) * 2010-02-09 2016-01-28 The Johns Hopkins University Methods and compositions for improving cognitive function
CA2807505A1 (en) 2010-08-24 2012-03-01 The Children's Hospital Of Philadelphia Association of rare recurrent genetic variations to attention-deficit, hyperactivity disorder (adhd) and methods of use thereof for the diagnosis and treatment of the same
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
CN103044307A (zh) * 2013-01-24 2013-04-17 吉林三善恩科技开发有限公司 以2,4-二羟基苯甲酸为前驱体的吡拉西坦药物共晶及其制备方法
CN103073477A (zh) * 2013-01-24 2013-05-01 吉林三善恩科技开发有限公司 以3,4-二羟基苯甲酸为前驱体的吡拉西坦药物共晶及其制备方法
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
JP6433482B2 (ja) 2013-03-15 2018-12-05 エージンバイオ, インコーポレイテッド 認知機能を改善するための方法および組成物
US11219617B2 (en) 2014-05-30 2022-01-11 The Children's Hospital Of Philadelphia Methods of diagnosing and treating autism
EP3148969B1 (en) * 2014-06-02 2020-11-11 Ketogen Inc. Compounds for the treatment of seizures and other central nervous system disorders and conditions
WO2016191288A1 (en) 2015-05-22 2016-12-01 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam
PL4023222T3 (pl) 2015-09-08 2025-03-24 The Children's Hospital Of Philadelphia Nieselektywny aktywator metabotropowych receptorów glutaminianu do leczenia zespołu 22q

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4355027A (en) * 1977-11-02 1982-10-19 Massachusetts Institute Of Technology Process and composition for treating disorders by administering piracetam and choline
CH657527A5 (de) * 1980-02-13 1986-09-15 Ciba Geigy Ag Verwendung von zentralnervoes-wirksamen verbindungen in einem mittel, welches zur verhinderung oder linderung von nebenwirkungen bestimmt ist.
GB8412357D0 (en) * 1984-05-15 1984-06-20 Ucb Sa Pharmaceutical composition
JPH0829140B2 (ja) * 1987-04-17 1996-03-27 開成工業株式会社 末▲梢▼循環機能障害診断用皮フ温測定装置
US6107492A (en) * 1998-05-08 2000-08-22 Ucb, S.A. Process for the preparation of levetiracetam
AR026610A1 (es) * 1999-12-01 2003-02-19 Ucb Sa Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central
GB0004297D0 (en) * 2000-02-23 2000-04-12 Ucb Sa 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses

Similar Documents

Publication Publication Date Title
JP2004523557A5 (https=)
JP5667684B2 (ja) 関節炎の治療方法
RU2006116887A (ru) Производные n-[гетероарил(пиперидин-2-ил)метил]бензамида, способ получения указанных соединений и их применение в терапии
CN1116870C (zh) 司立吉林在制备用于预防或治疗外周神经病的药物中的应用
RU94044671A (ru) Применение непептидных антагонистов рецептора тахикинина
EA200801165A1 (ru) Антагонисты неосновного рецептора-1 меланинконцентрирующего гормона
JP2005506352A5 (https=)
CA2528160A1 (en) Use of 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl) piperazine for neuronal regeneration and functional recovery
TW200621249A (en) Substituted amide beta secretase inhibitors
HUP0204526A2 (hu) 2-Oxo-1-pirrolidin-származékok, eljárás előállításukra és alkalmazásuk
CN102387704A (zh) S1p5受体的激动剂和拮抗剂,和其用法
JP2006507220A5 (https=)
RU2000114169A (ru) Замещенные производные имидазола, обладающие активностью, подобной активности агонистов, по отношению к адренергическим рецепторам альфа-2в или -2в/2с
JP2006503850A5 (https=)
RU2004136853A (ru) (s)-4-амино-5-хлор-2-метокси-n-[1-[1-(2-тетрагидрофурилкарбонил)-4- пиперидини лметил]-4-пиперидинил]бензамид, способ его получения, содержащая его фармацевтическая композиция и промежуточное соединение для его получения
US20040116505A1 (en) Treatment of tics, tremors and related disorders
RU2007128085A (ru) Соли четвертичного аммония в качестве антагонистов м3
AU2002245486A1 (en) Treatment of tics, tremors and related disorders
JP2022527618A5 (https=)
JP2008538583A5 (https=)
RU2006138495A (ru) Использование агонистов рецепторов, активируемых пролифератором пероксисомы дельта для лечения рс и других демиелинизирующих заболеваний
MXPA05010614A (es) Uso de derivados de 10-hidroxi-10,11-dihidrocarbamazepina para el tratamiento de trastornos afectivos.
JPH06500099A (ja) Cns疾病の処置におけるヘテロ環状アミノ―アルコール化合物の使用
RU2007128080A (ru) Производные пирролидиния в качестве мускариновых рецепторов мз
CA2534634A1 (en) Azolidinecarbonitriles and their use as dpp-iv inhibitors